-
H304266-1gapplication:A Camptothecin derivative: a topoisomerase inhibitor for cancer therapy.
-
H304266-5gapplication:A Camptothecin derivative: a topoisomerase inhibitor for cancer therapy.
-
H425263-1ml10-Hydroxycamptothecin.
-
I463812-1mgDescriptionNatural product derived from plant source.}.
-
M331517-100mg10-methoxy-3,4,5,6-tetrahydro-2H-1,5-benzoxazocine.
-
M302682-10mg10-Methoxycamptothecin is a natural bioactive derivative of camptothecin (CPT) isolated from Camptotheca acuminata, and has been confirmed to possess high anti-cancer properties. 10-Methoxycamptothecin has higher cytotoxicity than
-
M302682-1mg10-Methoxycamptothecin is a natural bioactive derivative of camptothecin (CPT) isolated from Camptotheca acuminata, and has been confirmed to possess high anti-cancer properties. 10-Methoxycamptothecin has higher cytotoxicity than
-
M302682-25mg10-Methoxycamptothecin is a natural bioactive derivative of camptothecin (CPT) isolated from Camptotheca acuminata, and has been confirmed to possess high anti-cancer properties. 10-Methoxycamptothecin has higher cytotoxicity than
-
M302682-5mg10-Methoxycamptothecin is a natural bioactive derivative of camptothecin (CPT) isolated from Camptotheca acuminata, and has been confirmed to possess high anti-cancer properties. 10-Methoxycamptothecin has higher cytotoxicity than
-
M668441-1mg10-Methyl-3-phenothiazinamine.
-
M668441-5mg10-Methyl-3-phenothiazinamine.
-